Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
September 30, 2026 -4.524M
June 30, 2026 -4.67M
March 31, 2026 -5.716M
December 31, 2025 -4.175M
September 30, 2025 -5.919M
June 30, 2025 -3.487M
March 31, 2025 -2.764M
December 31, 2024 -6.807M
September 30, 2024 -13.31M
June 30, 2024 -22.42M
March 31, 2024 -28.13M
December 31, 2023 -34.30M
September 30, 2023 -26.29M
June 30, 2023 -36.70M
March 31, 2023 -32.41M
December 31, 2022 -34.52M
September 30, 2022 -29.47M
June 30, 2022 -28.33M
March 31, 2022 -32.49M
December 31, 2021 -25.62M
Date Value
September 30, 2021 -19.98M
June 30, 2021 -12.42M
March 31, 2021 -13.90M
December 31, 2020 -12.10M
September 30, 2020 -10.96M
June 30, 2020 -7.218M
March 31, 2020 -8.032M
December 31, 2019 -9.484M
September 30, 2019 -7.177M
June 30, 2019 -6.317M
March 31, 2019 -6.551M
December 31, 2018 -4.090M
September 30, 2018 -6.100M
June 30, 2018 -2.966M
March 31, 2018 -6.788M
December 31, 2017
September 30, 2017 -5.655M
June 30, 2017 -4.988M
March 31, 2017 -7.366M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 519.00M
Bio-Rad Laboratories, Inc. 96.40M
Bruker Corp. 118.20M
Danaher Corp. 1.886B
Harvard Bioscience, Inc. -0.248M